The U.S. Patent and Trademark Office will begin proceeding that will determine the recipients of patents covering the use of CRISPR-Cas9 genome-editing technology. George Church (HMS) is mentioned.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?